Immunological configuration of ovarian carcinoma: features and impact on disease outcome.

Immunological configuration of ovarian carcinoma: features and impact on disease outcome.
复制标题

DOI:
10.1136/jitc-2021-002873
复制
发表时间:
2021-10
影响因子:
10.9
通讯作者:
Spisek R
Spisek R
中科院分区:
医学2区
文献类型:
--
作者:
Fucikova J;Coosemans A;Orsulic S;Cibula D;Vergote I;Galluzzi L;Spisek R

文献摘要

参考文献

被引文献

相似文献

上皮性卵巢癌(EOC)是一种相对罕见的恶性肿瘤,但却是女性癌症相关死亡的第五大原因,主要反映了早期、诊断前恶性疾病向腹膜的传播。与其他肿瘤不同的是,EOC实际上对免疫检查点抑制剂不敏感,这与肿瘤微环境有关,肿瘤微环境表现出免疫细胞浸润不良和主动免疫抑制。在这里,我们比较总结了原发性和转移性EOC的体液和细胞特征,比较分析了它们对疾病结局的影响,并提出了改变这些特征的措施,以支持治疗敏感性和更高的患者生存率。
Epithelial ovarian carcinoma (EOC) is a relatively rare malignancy but is the fifth-leading cause of cancer-related death in women, largely reflecting early, prediagnosis dissemination of malignant disease to the peritoneum. At odds with other neoplasms, EOC is virtually insensitive to immune checkpoint inhibitors, correlating with a tumor microenvironment that exhibits poor infiltration by immune cells and active immunosuppression. Here, we comparatively summarize the humoral and cellular features of primary and metastatic EOC, comparatively analyze their impact on disease outcome, and propose measures to alter them in support of treatment sensitivity and superior patient survival.
DOI: 10.1158/2159-8290.cd-20-0655
发表时间: 2021-01
期刊: Cancer discovery
影响因子: 28.2
作者:
Cózar B;Greppi M;Carpentier S;Narni-Mancinelli E;Chiossone L;Vivier E
通讯作者: Vivier E
DOI: 10.1186/1471-2407-13-422
发表时间: 2013-09-17
期刊: BMC CANCER
影响因子: 3.8
作者:
Bachmayr-Heyda, Anna;Aust, Stefanie;Castillo-Tong, Dan Cacsire
通讯作者: Castillo-Tong, Dan Cacsire
DOI: 10.3389/fimmu.2019.01273
发表时间: 2019-06-04
影响因子: 7.3
作者:
Baert, Thais;Vankerckhoven, Ann;Coosemans, An
通讯作者: Coosemans, An
DOI: 10.1172/jci123319
发表时间: 2019-03-01
影响因子: 15.9
作者:
Chabanon, Roman M.;Muirhead, Gareth;Postel-Vinay, Sophie
通讯作者: Postel-Vinay, Sophie
DOI: 10.1186/s40425-019-0623-z
发表时间: 2019-06-06
影响因子: 10.9
作者:
Andtbacka, Robert H., I;Collichio, Frances;Kaufman, Howard L.
通讯作者: Kaufman, Howard L.